14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
PRCH vs CURI: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, CuriosityStream Inc. (CURI) is the stronger overall head-to-head candidate over Porch Group, Inc. (PRCH) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). PRCH carries a Unified Composite Score of 47.3/100 (HOLD) at $20.92 (62.6x Forward P/E, 8.0% operating margin), whereas CURI carries 36.5/100 (SELL) at $3.21 (8.7x Forward P/E, 10.1% operating margin).
Composite vs. Pillar Nuance: While PRCH currently prints a higher short-term Unified Composite Score (47.3/100 HOLD vs. CURI 36.5/100 SELL), CURI captures the overall institutional head-to-head verdict (6–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (10.1% vs. 8.0% operating margin) and revenue trajectory (+12.9% vs. +13.0% YoY).
Competes within the Broadcasting value chain with $185.7M market capitalization and 10.1% operating margin.
OpEx & R&D Reinvestment50.1% of Rev ($39M)
90D Engineering Disclosures0 Published
Investor FAQ PRCH vs CURI Key Questions & Quantitative Answers
As of Nov 16, 2026, CuriosityStream Inc. (CURI) is the stronger overall head-to-head candidate over Porch Group, Inc. (PRCH) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). PRCH carries a Unified Composite Score of 47.3/100 (HOLD) at $20.92 (62.6x Forward P/E, 8.0% operating margin), whereas CURI carries 36.5/100 (SELL) at $3.21 (8.7x Forward P/E, 10.1% operating margin). Composite vs. Pillar Nuance: While PRCH currently prints a higher short-term Unified Composite Score (47.3/100 HOLD vs. CURI 36.5/100 SELL), CURI captures the overall institutional head-to-head verdict (6–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (10.1% vs. 8.0% operating margin) and revenue trajectory (+12.9% vs. +13.0% YoY).
PRCH leads the Growth & Scale pillar: PRCH posts +13.0% YoY revenue growth and +155.3% YoY earnings growth on $530M TTM revenue (72.1% gross margin, 8.0% operating margin), compared with CURI at +12.9% YoY revenue growth and N/A YoY earnings growth on $78M TTM revenue (60.2% gross margin, 10.1% operating margin). Across the 7-period historical trajectory (FY2019 to FY2025), PRCH cumulative revenue shifted +425.0% while CURI shifted +250.0%. In operating R&D and SG&A reinvestment, PRCH deploys 64.1% of Rev ($340M) (0 90-day corporate R&D disclosures) versus 50.1% of Rev ($39M) (0 disclosures) for CURI.
CURI screens cheaper on headline valuation multiples. PRCH trades at 62.6x Forward P/E, N/M Trailing P/E, N/M PEG, and 4.9x EV/Revenue (18.6% FCF margin), whereas CURI trades at 8.7x Forward P/E, 20.9x Trailing P/E, N/M PEG, and N/M EV/Revenue (31.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PRCH (5.6% ROE) versus CURI (19.3% ROE) capital efficiency.
In options market volatility and institutional positioning, PRCH carries 63.6% implied volatility (13th %ile, Compressed (<25th %ile)), a 0.02x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKOUT options structure phase (1.59β · 114% Vol realized risk). By comparison, CURI carries 99.3% implied volatility (55th %ile, Balanced (25th–60th %ile)), a 0.88x (Balanced) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.29β · 94% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.